4.8 (639) In stock
An investigational typhoid vaccine containing a component developed with NIAID funding may overcome some of the shortcomings of available typhoid vaccines, according to a paper published in the journal Vaccine in June.
News - VaccineNation
Mucosal vaccine delivery: Current state and a pediatric
Stages in COVID-19 vaccine development: The Nemesis, the Hubris
Vaccine value profile for enterotoxigenic Escherichia coli (ETEC
Frontiers Progress and Pitfalls in the Quest for Effective SARS
Mucosal vaccines — fortifying the frontiers
Frontiers Polyphosphazenes as Adjuvants for Animal Vaccines and
Adjuvant Development NIAID: National Institute of Allergy and
Controlled Human Infection Models To Accelerate Vaccine
Transcriptional correlates of malaria in RTS,S/AS01-vaccinated
Immune responses induced by different vaccine platforms against
Bioengineering, Free Full-Text
